Lv6
2270 积分 2023-08-21 加入
Lepodisiran - A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
12天前
已完结
10.1056/NEJMoa2415818
12天前
已关闭
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)
12天前
已完结
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
12天前
已完结
Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial
12天前
已完结
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
12天前
已完结
Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
12天前
已完结
Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
12天前
已完结
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
12天前
已完结
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications
12天前
已完结
皖公网安备34019202002308
